Jump to:

Philip Morris

Date: 12 May 1978
Length: 1 page
1003710268
Jump To Images
snapshot_pm 1003710268

Fields

Author
Klarberg, R.B.
Area
SELIGMAN,ROBERT
Type
LETT, LETTER
Copied
R, S.
Seligman, R.B.
S, R.B. <Seligman, R.B.>
Request
Stmn/R1-004
Stmn/R1-149
Recipient
Seligman, R.B.
Document File
1003710125/1003710305/American Heath Foundation. Missing
Litigation
Stmn/Produced
Author (Organization)
Ahf, American Health Foundation
Master ID
1003710268/0270
Related Documents:
Characteristic
MARG, MARGINALIA
Site
R35
Date Loaded
05 Jun 1998
UCSF Legacy ID
szw97e00

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: szw97e00 Log in for more options!
AM E RIiCAN H EALTH FOUN 320 East'43rd Street; New York, New YOrk,1D01'7 (212) 4894700 Naylor Dana Institute for Disease Prevention Valhalla, NJY. 10595 Pho ne: 9,1 tl,-592=2ti00 R 11: CEI V E D MAY 17 1978 R. B. SELIGMAN May U, 1978 OFFICERS AND BOARD OFTRUSTEES David J. Mahoney, Chairman Chairman and Chief'Executive Offlcer Norton Simond Inc. William J. Levitt, Past Chairman Founder-Chairman LevitY3'Sons, Inc. Ernst L. Wynder, M.D., Presitlent' John D. Twiname, ManagingDlrector Eric M. Javita; Secretary Senior Partner Javits 6,Javits Warner G. Cosgrove, Jt., Treasurer TRUSTEES: John J. Burns. Ph.D. "` Vice President fon Research Hoffmann+La Roche;, Inc. Thomas L. Chrystie Senior Vice President Merrill Lynch & Co. Inc. Mrs. Charles A: Dana D. Ronald Daniel Managing Director, ; McKinsey A' Company, Inc. Ralph Landau, Sc.D. Chairman & Chief'Executive Officer Halcon International, Inc. 5, Hildegard E. Merrill Joseph Robbie Managing Partner Miami Dolphins. Ltd. :John W.Simmns `.Presidenf8 Chief'Executive Officer Morton-Norwich Products, Inc. Mrs. Jennifer Jones Simon ;.. Thomas A. WAtson ADM. E.,R. Zumwalt;,Jr>, USN(Ret.)', David L. Davies Executive Vice President JohniH. Weisburger, Ph.D. Vice PresJdentfor Research ~ DATION Robert B. Seligman, Ph.D. Vice-President, Research and Deve].opment. PhiliplNlorris Research Center Richmond~, V'irginia, Dear Dr. Seligman, I am pleased to enclose an executed assignment of patent agreement regarding scaven- ger reactions of NOX. Please note that in Paragraph 2 1 added a statement to clarify the fact that the assign- ment is'applicable only to research in this area which has been funded by your company. Looking forward to see'ing you soon again, I am RBK/mh -ficerely, R~ ~ch rd B. I~~ S~ le al Counse

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: